• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Datavault AI Converts $13.3 Million in Convertible Debt, Strengthens Balance Sheet

    10/2/25 6:18:56 PM ET
    $DVLT
    $SCLX
    Semiconductors
    Technology
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $DVLT alert in real time by email

    BEAVERTON, Ore., Oct. 02, 2025 (GLOBE NEWSWIRE) -- via IBN – Datavault AI Inc. (NASDAQ:DVLT), a pioneer in AI-driven data monetization, today announced the full conversion of certain long term notes with an aggregate original face value of $13.3 million thereby  strengthening its balance sheet substantially.

    Commenting on the debt conversion, Brett Moyer, Datavault AI Chief Financial Officer, said, "Converting these notes is an important strategic milestone and supports the accelerated launch of our independent data exchanges (IDEs) and building out our supercomputing capabilities in cooperation with IBM."

    Today's news follows the Company's announcement on September 25 that it had secured a $150 million strategic equity investment, in Bitcoin, from Nasdaq-listed biotech company Scilex (NASDAQ:SCLX) -- as biotech is a Datavault AI primary target customer market sector.

    About Datavault AI

    Datavault AI™ (NASDAQ:DVLT) is leading the way in AI driven data experiences, valuation and monetization of assets in the Web 3.0 environment. The company's cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Science and Data Science Divisions. Datavault AI's Acoustic Science Division features WiSA®, ADIO® and Sumerian® patented technologies and industry-first foundational spatial and multichannel wireless HD sound transmission technologies with IP covering audio timing, synchronization and multi-channel interference cancellation. The Data Science Division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization. Datavault AI's cloud-based platform provides comprehensive solutions serving multiple industries, including HPC software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange® (IDE) enables Digital Twins, licensing of name, image and likeness (NIL) by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI with integrity. Datavault AI's technology suite is completely customizable and offers AI and Machine Learning (ML) automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The company is headquartered in Beaverton, OR. Learn more about Datavault AI at www.dvlt.ai.

    Forward Looking Statements Disclaimer

    This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and other securities laws. Words such as "expect," "will," "anticipates," "continues" and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. Such forward-looking statements, including statements herein regarding our business opportunities and prospects, strategy, future revenue expectations, licensing initiatives, patent initiatives as well as the successful implementation of the patented technologies, are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various risks and uncertainties including, but not limited to, the following: our ability to successfully utilize all intellectual property that has been issued and granted Notices of Allowance; risks regarding our ability to utilize the assets we acquire to successfully grow our market share; risks regarding our ability to open up new revenue streams as a result of the various patents mentioned in this press release; our current liquidity position and the need to obtain additional financing to support ongoing operations; general market, economic and other conditions; our ability to continue as a going concern; our ability to maintain the listing of our common stock on Nasdaq; our ability to manage costs and execute on our operational and budget plans; our ability to achieve our financial goals; the degree to which our licensees implement our technologies into their products, if at all; the timeline to any such implementation; risks related to technology innovation and intellectual property, and other risks as more fully described in our filings with the U.S. Securities and Exchange Commission. The information in this press release is provided only as of the date of this press release, and we undertake no obligation to update any forward-looking statements contained in this communication based on new information, future events, or otherwise, except as required by law.

    Investor Contact

    800.491.9665

    [email protected]

    Wire Service Contact:

    IBN

    Austin, Texas

    www.InvestorBrandNetwork.com

    512.354.7000 Office

    [email protected]



    Primary Logo

    Get the next $DVLT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DVLT
    $SCLX

    CompanyDatePrice TargetRatingAnalyst
    Scilex Holding Company
    $SCLX
    1/27/2025$22.00Buy
    D. Boral Capital
    Scilex Holding Company
    $SCLX
    10/16/2024$14.00Buy
    Alliance Global Partners
    Scilex Holding Company
    $SCLX
    6/13/2024$13.00Buy
    Rodman & Renshaw
    Scilex Holding Company
    $SCLX
    10/16/2023$4.00Buy
    B. Riley Securities
    Scilex Holding Company
    $SCLX
    10/13/2023$4.00Buy
    B. Riley Securities
    Scilex Holding Company
    $SCLX
    10/9/2023$12.00Buy
    H.C. Wainwright
    More analyst ratings

    $DVLT
    $SCLX
    SEC Filings

    View All

    SEC Form PRE 14A filed by Scilex Holding Company

    PRE 14A - Scilex Holding Co (0001820190) (Filer)

    10/28/25 5:22:48 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Datavault AI Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Datavault AI Inc. (0001682149) (Filer)

    10/28/25 4:06:49 PM ET
    $DVLT
    Semiconductors
    Technology

    SEC Form 424B5 filed by Datavault AI Inc.

    424B5 - Datavault AI Inc. (0001682149) (Filer)

    10/28/25 4:05:21 PM ET
    $DVLT
    Semiconductors
    Technology

    $DVLT
    $SCLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    D. Boral Capital initiated coverage on Scilex Holding with a new price target

    D. Boral Capital initiated coverage of Scilex Holding with a rating of Buy and set a new price target of $22.00

    1/27/25 8:08:33 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Alliance Global Partners initiated coverage on Scilex Holding with a new price target

    Alliance Global Partners initiated coverage of Scilex Holding with a rating of Buy and set a new price target of $14.00

    10/16/24 8:01:57 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Rodman & Renshaw initiated coverage on Scilex Holding with a new price target

    Rodman & Renshaw initiated coverage of Scilex Holding with a rating of Buy and set a new price target of $13.00

    6/13/24 7:16:15 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $DVLT
    $SCLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Wu Yue Alexander

    4 - Scilex Holding Co (0001820190) (Issuer)

    10/9/25 8:47:29 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by CFO and COO Ma Stephen Hoi

    4 - Scilex Holding Co (0001820190) (Issuer)

    10/9/25 8:45:23 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Director Chun Jay

    4 - Scilex Holding Co (0001820190) (Issuer)

    10/9/25 8:43:50 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $DVLT
    $SCLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Shah Jaisim bought $13,800 worth of shares (30,000 units at $0.46), increasing direct ownership by 27% to 139,333 units (SEC Form 4)

    4 - Scilex Holding Co (0001820190) (Issuer)

    12/18/24 7:04:41 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Executive Chairperson Ji Henry bought $8,351 worth of shares (8,888 units at $0.94), increasing direct ownership by 3% to 320,161 units (SEC Form 4)

    4 - Scilex Holding Co (0001820190) (Issuer)

    10/31/24 12:44:57 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Officer Shah Jaisim bought $31,670 worth of shares (32,000 units at $0.99), increasing direct ownership by 41% to 109,333 units (SEC Form 4)

    4 - Scilex Holding Co (0001820190) (Issuer)

    10/29/24 6:59:31 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $DVLT
    $SCLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Datavault AI Acquires API Media in All Cash Transaction

    PHILADELPHIA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- via IBN – Datavault AI Inc. (NASDAQ:DVLT), a leader in patented data tokenization and monetization technologies, today announced that it has entered into a definitive acquisition agreement to acquire API Media in December of this year. Through API's strength of technology culture and seasoned leadership team, Datavault AI and API will enhance enterprise data activation, expand AI-powered capabilities, and drive new monetization opportunities across global markets. The API brand will remain, and operations will be enhanced with the addition of patented capabilities and technologies developed and patented by Datavault AI. API Media, headquart

    10/28/25 2:48:15 PM ET
    $DVLT
    Semiconductors
    Technology

    Nature's Miracle Crowns Datavault AI with 35% Royalty License with Multi-Million-Dollar Global Technology License

    Company Further Monetizes its data over sound ADIO® and patented Data Vault® Platform featuring the industry leading DataScore® and DataValue® agents that will now exclusively power Nature's Miracle's Carbon Credit, Tokenized RWA Initiatives and VerifyU™ blockchain credentialing Nature's Miracle is doubling down on the green economy and the generational importance of renewable energy and clean air, water and food supplies with a focus on Hong Kong and Pac-Rim regionsNature's Miracle Focuses on the Power of our Sun through Blockchain-Based Carbon Credit Tokenization & Green Blockchain Initiatives with XRP Focused Solutions for Enterprise Tandem Focused on Producing ARR Annual Recurring Revenu

    10/28/25 9:42:23 AM ET
    $DVLT
    $NMHI
    Semiconductors
    Technology
    Industrial Machinery/Components
    Industrials

    Nature's Miracle Crowns Datavault AI with 35% Royalty License with Multi-Million-Dollar Global Technology License

    Nature's Miracle and Datavault AI Already Actively Tokenizing RWA Projects in Taiwan, Japan, South Korea and China to Trade Exclusively on Datavault AI's Information Data Exchange ® Company Further Monetizes its data over sound ADIO ® and patented Data Vault ® Platform featuring the industry leading DataScore® and DataValue ® agents that will now exclusively power Nature's Miracle's Carbon Credit, Tokenized RWA Initiatives and VerifyU™ blockchain credentialingNature's Miracle is doubling down on the green economy and the generational importance of carbon credit in Asia including Japan, Taiwan and South Korea.Nature's Miracle Focuses on the Power of our Sun through Blockchain-Based Carbon Cre

    10/28/25 9:25:00 AM ET
    $DVLT
    $NMHI
    Semiconductors
    Technology
    Industrial Machinery/Components
    Industrials

    $DVLT
    $SCLX
    Leadership Updates

    Live Leadership Updates

    View All

    Datavault AI Appoints U.S. Navy Veteran Pete Scobell as Vice President, Global Security

    BEAVERTON, Ore., Oct. 21, 2025 (GLOBE NEWSWIRE) -- via IBN -- Datavault AI Inc. (NASDAQ:DVLT), leading the way in AI data experience, valuation, and monetization, today announced the appointment of Pete Scobell as Vice President, Global Security. A decorated U.S. Navy SEAL veteran, Scobell will oversee Datavault AI's global security operations, risk management, and the execution of real-world asset logistics activity across all regions. Scobell's appointment comes as Datavault AI continues to advance its Anti-Stolen Valor initiative, first announced earlier this year, honoring military service, integrity, and accountability through a values-driven, data-backed ecosystem. The program reinf

    10/21/25 6:05:00 AM ET
    $DVLT
    Semiconductors
    Technology

    Datavault AI Updates 4th Quarter, 2025 Outlook

    ·Company Incorporates Four Innovative Independent Data Exchanges with Expected Q4-25 Revenue Contribution ·Exchanges Expected to be Bolstered by Foundational Patents in the Tokenomics Economy ·Begins Enforcement Initiative with Top Tier Banks Led by Leading IP Firm BEAVERTON, Ore., Oct. 06, 2025 (GLOBE NEWSWIRE) -- via IBN – Datavault AI Inc. (NASDAQ:DVLT), a pioneer in AI-driven tokenization and data monetization, today updated its 4th quarter of 2025 outlook and 2026 revenue guidance.  Highlights of the Company's Q4-25 outlook includes: ·Incorporating four innovative independent data exchanges ·Enhancing its patent portfolio, now exceeding 70 patents/filings, focused on c

    10/6/25 6:00:00 AM ET
    $DVLT
    Semiconductors
    Technology

    Scilex Holding Company Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D.

    PALO ALTO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:SCLX, "Scilex" or the "Company"))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that it has added to its Board of Directors a highly accomplished leader in interventional and multidisciplinary spine, musculoskeletal and orthopedic care, Annu Navani, M.D. Dr. Navani has served as the Chief Executive Officer of Comprehensive Spine and Sports Center since 2008, a leader in interventional and multidisciplinary spine, musculoskeletal, and orthopedic care. Over th

    7/23/24 9:00:00 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $DVLT
    $SCLX
    Financials

    Live finance-specific insights

    View All

    Datavault AI Acquires API Media in All Cash Transaction

    PHILADELPHIA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- via IBN – Datavault AI Inc. (NASDAQ:DVLT), a leader in patented data tokenization and monetization technologies, today announced that it has entered into a definitive acquisition agreement to acquire API Media in December of this year. Through API's strength of technology culture and seasoned leadership team, Datavault AI and API will enhance enterprise data activation, expand AI-powered capabilities, and drive new monetization opportunities across global markets. The API brand will remain, and operations will be enhanced with the addition of patented capabilities and technologies developed and patented by Datavault AI. API Media, headquart

    10/28/25 2:48:15 PM ET
    $DVLT
    Semiconductors
    Technology

    Datavault AI Announces Entity Affiliated with CEO Acquires 10 Million Shares of DVLT Common Stock

    Datavault AI Inc. (NASDAQ:DVLT), ("Datavault AI") a pioneer in AI-driven data and acoustic sciences, today announced that EOS Technology Holdings Inc. ("EOS") has converted $3,200,000 of a convertible promissory note issued by Datavault AI to EOS into 10 million shares of common stock of Datavault AI. Datavault AI CEO Nathaniel Bradley, a recognized expert in AI and data technologies, is the chief executive officer and sole director of EOS. This investment underscores EOS' confidence in Datavault AI's patent portfolio, innovative platforms, and leadership in setting industry standards for technology licensing in acoustic, data sciences and management frameworks. "I believe Datavault AI re

    9/8/25 6:35:00 AM ET
    $DVLT
    Semiconductors
    Technology

    Datavault AI Q2 2025 Recognized Revenue of $1.7M, Reflecting 467% Year-Over-Year Growth and Booked a $2.5M Licensing Deal with Nyiax

    Establishing Annual Recurring Revenue (ARR) from Patented AI Agentic Platforms and Technology Licensing, Along with Pending Closure of API Media Acquisition, Set to Contribute to Record-Breaking Revenue Generation and Market Momentum in 2025 Management targeting annual cost-efficiency measures, yielding total savings exceeding $4 million by 2026 while optimizing for continued growth Datavault AI Inc. (NASDAQ:DVLT), a leader in AI-powered data monetization and exchange solutions, today reported strong financial performance for the second quarter ended June 30, 2025. Recognized revenue rose to $1.7 million, up significantly from $0.3 million in Q2 2024—a 467% year-over-year increase—while

    8/20/25 7:37:00 AM ET
    $DVLT
    Semiconductors
    Technology

    $DVLT
    $SCLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Scilex Holding Company (Amendment)

    SC 13D/A - Scilex Holding Co (0001820190) (Subject)

    4/25/24 5:25:28 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13D/A filed by Scilex Holding Company (Amendment)

    SC 13D/A - Scilex Holding Co (0001820190) (Subject)

    3/5/24 4:22:28 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care